Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.32 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.32 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1532435 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL872893 | 1.00 | LMNA (0.52) | LMNALPAR2LPAR3LPAR1THRB | |
| SCHEMBL3270977 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL3508513 | 0.93 | LMNA (0.39) | LMNALPAR2LPAR3LPAR1 | |
| SCHEMBL27565987 | 0.81 | LMNA (0.50) | LMNA | |
| SCHEMBL16902064 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL16902072 | 0.79 | LPAR2 (0.34) | LPAR2LPAR3LPAR1 | |
| SCHEMBL26001345 | 0.78 | LPAR2 (0.47) | LMNALPAR2LPAR3LPAR1NR1I2 | |
| SCHEMBL3673217 | 0.78 | LMNA (0.46) | LMNA | |
| SCHEMBL3673215 | 0.78 | LMNA (0.46) | LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 289 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | GIVAUDAN SA (CH) | 2026-03-31 | — | — | US | claimed |
| EP-4695016-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2026-02-18 | — | — | EP | claimed |
| US-12496370-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2025-12-16 | — | — | US | claimed |
| US-20250295826-A1 | FRAGRANCES AS UREASE INHIBITORS | SYMRISE AG (DE) | 2025-09-25 | — | — | US | claimed |
| EP-4527191-A1 | UREASE INHIBITORS | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| WO-2024213507-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2024-10-17 | — | — | WO | claimed |
| EP-4446001-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | Givaudan SA (CH) | 2024-10-16 | — | — | EP | claimed |
| US-11806448-B2 | Freshening compositions comprising controlled release modulators | Arylessence, Inc. (US) | 2023-11-07 | — | — | US | claimed |
| US-20230340374-A1 | Improvements in or Relating to Organic Compounds | GIVAUDAN SA (CH) | 2023-10-26 | — | — | US | claimed |
| EP-4257663-A1 | FOOD CONTACT SURFACE SANITIZING LIQUID | The Procter & Gamble Company (US) | 2023-10-11 | — | — | EP | claimed |
| CN-115297822-A | Consumer product comprising a plurality of microcapsules defined by an average total surface area | 奇华顿股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| US-11364184-B2 | Perfume compositions | GIVAUDAN SA (CH) | 2022-06-21 | — | — | US | claimed |
| WO-2021213930-A1 | IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS | GIVAUDAN SA (CH) | 2021-10-28 | — | — | WO | claimed |
| WO-2021185736-A1 | CONSUMER PRODUCT COMPRISING A PLURALITY OF MICROCAPSULES DEFINED BY THE MEAN TOTAL SURFACE AREA | GIVAUDAN SA (CH) | 2021-09-23 | — | — | WO | claimed |
| EP-3155084-B1 | DISHWASHER DETERGENT FRAGRANCE COMPOSITION | GIVAUDAN SA (CH) | 2018-11-07 | — | — | EP | claimed |
| CN-1853603-B | Stable composition for hair dye | TAKASAGO PERFUMERY CO LTD | 2014-02-12 | — | — | CN | claimed |
| US-7399318-B2 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2008-07-15 | — | — | US | claimed |
| CN-1853603-A | Stable composition for hair dye comprising a fragrance | TAKASAGO PERFUMERY CO LTD (JP) | 2006-11-01 | — | — | CN | claimed |
| EP-1714637-A2 | Stable composition for hair dye comprising a fragrance | Takasago International Corporation (JP) | 2006-10-25 | — | — | EP | claimed |
| US-20060218730-A1 | Stable composition for hair dye | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2006-10-05 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12589377-B2 | Encapsulated composition comprising core-shell microcapsules and process for its preparation | CUTA, EXOC1, EXOSC10 | LMNA 1922/4885LPAR2 4658/4885LPAR3 4745/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.